RG
ZBH icon

Rathbones Group’s Zimmer Biomet ZBH Stock Holding History

Rathbones Group’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$758K Sell
8,386
-4,505
-35% -$413K ﹤0.01% 405
2025
Q4 		$1.16M Sell
12,891
-3,522
-21% -$334K ﹤0.01% 350
2025
Q3 		$1.62M Sell
16,413
-2,080
-11% -$206K 0.01% 306
2025
Q2 		$1.69M Sell
18,493
-109
-0.6% -$10.5K 0.01% 301
2025
Q1 		$2.11M Sell
18,602
-318
-2% -$34K 0.01% 275
2024
Q4 		$2M Sell
18,920
-870
-4% -$93.3K 0.01% 281
2024
Q3 		$2.14M Sell
19,790
-270
-1% -$29.5K 0.01% 270
2024
Q2 		$2.18M Sell
20,060
-15,384
-43% -$1.81M 0.01% 259
2024
Q1 		$4.68M Sell
35,444
-245
-0.7% -$30.6K 0.03% 193
2023
Q4 		$4.34M Sell
35,689
-1,429
-4% -$159K 0.03% 191
2023
Q3 		$4.17M Buy
37,118
+636
+2% +$80.8K 0.03% 195
2023
Q2 		$5.31M Buy
36,482
+2,888
+9% +$392K 0.05% 145
2023
Q1 		$4.34M Sell
33,594
-37
-0.1% -$4.64K 0.04% 157
2022
Q4 		$4.29M Sell
33,631
-95
-0.3% -$11K 0.05% 152
2022
Q3 		$3.53M Sell
33,726
-317
-0.9% -$34.8K 0.04% 160
2022
Q2 		$3.58M Sell
34,043
-1,498
-4% -$178K 0.04% 172
2022
Q1 		$4.55M Sell
35,541
-1,382
-4% -$167K 0.05% 162
2021
Q4 		$4.55M Buy
36,923
+4,930
+15% +$645K 0.04% 164
2021
Q3 		$4.55M Buy
31,993
+701
+2% +$103K 0.05% 159
2021
Q2 		$4.89M Buy
31,292
+210
+0.7% +$34K 0.05% 157
2021
Q1 		$4.83M Buy
31,082
+242
+0.8% +$37.5K 0.06% 147
2020
Q4 		$4.61M Buy
30,840
+1,509
+5% +$213K 0.07% 143
2020
Q3 		$3.88M Buy
29,331
+15,662
+115% +$2.05M 0.07% 137
2020
Q2 		$1.58M Buy
+13,669
New +$1.58M 0.03% 175

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Rathbones Group's ZBH Position: Q1 2026 in Review

Rathbones Group reduced its Zimmer Biomet (ZBH) stake by 35% in Q1 2026, selling an estimated $413K and leaving 8,386 shares worth $758K. The position accounts for ﹤0.01% of the portfolio, ranked #405.

Rathbones Group first reported a position in ZBH in Q2 2020 and has held it in 24 quarters since. The position peaked at $5.31M in Q2 2023. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Rathbones Group held 8,386 shares of Zimmer Biomet worth $758K as of Q1 2026.
  • Rathbones Group sold 4,505 Zimmer Biomet shares in Q1 2026, an estimated $413K.
  • Zimmer Biomet made up ﹤0.01% of Rathbones Group's portfolio in Q1 2026, its #405 holding.
  • Rathbones Group first reported a position in Zimmer Biomet in Q2 2020 and has held it in 24 quarters since.
  • Rathbones Group's Zimmer Biomet position peaked at $5.31M in Q2 2023.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Rathbones Group's 13F filing for Q1 2026, filed 12 May 2026.